Advertisement

Index by author

February 01, 1985; Volume 27,Issue 2

A

  1. Akamatsu, N

    1. Age-related alterations in the catecholamine-sensitive adenylate cyclase system of the prostate.
      S Shima, N Akamatsu, M Hirai and H Kouyama
      Molecular Pharmacology February 1985, 27 (2) 218-222;

  2. Albuquerque, E X

    1. Triphenylmethylphosphonium blocks the nicotinic acetylcholine receptor noncompetitively.
      C E Spivak and E X Albuquerque
      Molecular Pharmacology February 1985, 27 (2) 246-255;

B

  1. Bergman, A

    1. Target cells for the polychlorinated biphenyl metabolite 4,4'-bis(methylsulfonyl)-2,2',5,5'-tetrachlorobiphenyl. Characterization of high affinity binding in rat and mouse lung cytosol.
      J Lund, I Brandt, L Poellinger, A Bergman, E Klasson-Wehler and J A Gustafsson
      Molecular Pharmacology February 1985, 27 (2) 314-323;

  2. Billings, R E

    1. Bromobenzene metabolism in isolated rat hepatocytes. 18O2 incorporation studies.
      D Dankovic, R E Billings, W Seifert and W G Stillwell
      Molecular Pharmacology February 1985, 27 (2) 287-295;

  3. Brandt, I

    1. Target cells for the polychlorinated biphenyl metabolite 4,4'-bis(methylsulfonyl)-2,2',5,5'-tetrachlorobiphenyl. Characterization of high affinity binding in rat and mouse lung cytosol.
      J Lund, I Brandt, L Poellinger, A Bergman, E Klasson-Wehler and J A Gustafsson
      Molecular Pharmacology February 1985, 27 (2) 314-323;

  4. Brodersen, R

    1. Interaction of warfarin with human serum albumin. A stoichiometric description.
      F G Larsen, C G Larsen, P Jakobsen and R Brodersen
      Molecular Pharmacology February 1985, 27 (2) 263-270;

C

  1. Carter, E A

    1. Rapid reciprocal changes in adrenergic receptors in intact isolated hepatocytes during primary cell culture.
      K R Schwarz, S M Lanier, E A Carter, C J Homcy and R M Graham
      Molecular Pharmacology February 1985, 27 (2) 200-209;

  2. Cohen, M B

    1. Cytotoxicity and the inhibition of ribosomal RNA processing in human colon carcinoma cells.
      M B Cohen and R I Glazer
      Molecular Pharmacology February 1985, 27 (2) 308-313;

  3. Creese, I

    1. Interactions of dopamine agonists with brain D1 receptors labeled by 3H-antagonists. Evidence for the presence of high and low affinity agonist-binding states.
      S E Leff, M W Hamblin and I Creese
      Molecular Pharmacology February 1985, 27 (2) 171-183;
    2. Interactions of dopaminergic agonists and antagonists with dopaminergic D3 binding sites in rat striatum. Evidence that [3H]dopamine can label a high affinity agonist-binding state of the D1 dopamine receptor.
      S E Leff and I Creese
      Molecular Pharmacology February 1985, 27 (2) 184-192;

  4. Crooke, S T

    1. Characterization of guinea pig myocardial leukotriene C4 binding sites. Regulation by cations and sulfhydryl-directed reagents.
      G K Hogaboom, S Mong, J M Stadel and S T Crooke
      Molecular Pharmacology February 1985, 27 (2) 236-245;

D

  1. Danenberg, P V

    1. Assay and time course of 5-fluorouracil incorporation into RNA of L1210/0 ascites cells in vivo.
      C P Spears, J Shani, A H Shahinian, W Wolf, C Heidelberger and P V Danenberg
      Molecular Pharmacology February 1985, 27 (2) 302-307;

  2. Dankovic, D

    1. Bromobenzene metabolism in isolated rat hepatocytes. 18O2 incorporation studies.
      D Dankovic, R E Billings, W Seifert and W G Stillwell
      Molecular Pharmacology February 1985, 27 (2) 287-295;

G

  1. Glazer, R I

    1. Cytotoxicity and the inhibition of ribosomal RNA processing in human colon carcinoma cells.
      M B Cohen and R I Glazer
      Molecular Pharmacology February 1985, 27 (2) 308-313;

  2. Graham, R M

    1. Rapid reciprocal changes in adrenergic receptors in intact isolated hepatocytes during primary cell culture.
      K R Schwarz, S M Lanier, E A Carter, C J Homcy and R M Graham
      Molecular Pharmacology February 1985, 27 (2) 200-209;

  3. Guan, J H

    1. A photoaffinity ligand for dopamine D2 receptors: azidoclebopride.
      H B Niznik, J H Guan, J L Neumeyer and P Seeman
      Molecular Pharmacology February 1985, 27 (2) 193-199;

  4. Gullberg, D

    1. Characterization of the hydrophobic properties of the receptor for 2,3,7,8-tetrachlorodibenzo-p-dioxin.
      L Poellinger and D Gullberg
      Molecular Pharmacology February 1985, 27 (2) 271-276;

  5. Gustafsson, J A

    1. Target cells for the polychlorinated biphenyl metabolite 4,4'-bis(methylsulfonyl)-2,2',5,5'-tetrachlorobiphenyl. Characterization of high affinity binding in rat and mouse lung cytosol.
      J Lund, I Brandt, L Poellinger, A Bergman, E Klasson-Wehler and J A Gustafsson
      Molecular Pharmacology February 1985, 27 (2) 314-323;

H

  1. Hamblin, M W

    1. Interactions of dopamine agonists with brain D1 receptors labeled by 3H-antagonists. Evidence for the presence of high and low affinity agonist-binding states.
      S E Leff, M W Hamblin and I Creese
      Molecular Pharmacology February 1985, 27 (2) 171-183;

  2. Heidelberger, C

    1. Assay and time course of 5-fluorouracil incorporation into RNA of L1210/0 ascites cells in vivo.
      C P Spears, J Shani, A H Shahinian, W Wolf, C Heidelberger and P V Danenberg
      Molecular Pharmacology February 1985, 27 (2) 302-307;

  3. Hirai, M

    1. Age-related alterations in the catecholamine-sensitive adenylate cyclase system of the prostate.
      S Shima, N Akamatsu, M Hirai and H Kouyama
      Molecular Pharmacology February 1985, 27 (2) 218-222;

  4. Hoffman, B B

    1. Desensitization of beta-adrenergic receptor-mediated vascular smooth muscle relaxation.
      G Tsujimoto and B B Hoffman
      Molecular Pharmacology February 1985, 27 (2) 210-217;

  5. Hogaboom, G K

    1. Characterization of guinea pig myocardial leukotriene C4 binding sites. Regulation by cations and sulfhydryl-directed reagents.
      G K Hogaboom, S Mong, J M Stadel and S T Crooke
      Molecular Pharmacology February 1985, 27 (2) 236-245;

  6. Homcy, C J

    1. Rapid reciprocal changes in adrenergic receptors in intact isolated hepatocytes during primary cell culture.
      K R Schwarz, S M Lanier, E A Carter, C J Homcy and R M Graham
      Molecular Pharmacology February 1985, 27 (2) 200-209;

J

  1. Jakobsen, P

    1. Interaction of warfarin with human serum albumin. A stoichiometric description.
      F G Larsen, C G Larsen, P Jakobsen and R Brodersen
      Molecular Pharmacology February 1985, 27 (2) 263-270;

  2. Johnson, E F

    1. Variations among untreated rabbits in benzo(a)pyrene metabolism and its modulation by 7,8-benzoflavone.
      J L Raucy and E F Johnson
      Molecular Pharmacology February 1985, 27 (2) 296-301;

K

  1. Klasson-Wehler, E

    1. Target cells for the polychlorinated biphenyl metabolite 4,4'-bis(methylsulfonyl)-2,2',5,5'-tetrachlorobiphenyl. Characterization of high affinity binding in rat and mouse lung cytosol.
      J Lund, I Brandt, L Poellinger, A Bergman, E Klasson-Wehler and J A Gustafsson
      Molecular Pharmacology February 1985, 27 (2) 314-323;

  2. Kouyama, H

    1. Age-related alterations in the catecholamine-sensitive adenylate cyclase system of the prostate.
      S Shima, N Akamatsu, M Hirai and H Kouyama
      Molecular Pharmacology February 1985, 27 (2) 218-222;

L

  1. Lanier, S M

    1. Rapid reciprocal changes in adrenergic receptors in intact isolated hepatocytes during primary cell culture.
      K R Schwarz, S M Lanier, E A Carter, C J Homcy and R M Graham
      Molecular Pharmacology February 1985, 27 (2) 200-209;

  2. Larsen, C G

    1. Interaction of warfarin with human serum albumin. A stoichiometric description.
      F G Larsen, C G Larsen, P Jakobsen and R Brodersen
      Molecular Pharmacology February 1985, 27 (2) 263-270;

  3. Larsen, F G

    1. Interaction of warfarin with human serum albumin. A stoichiometric description.
      F G Larsen, C G Larsen, P Jakobsen and R Brodersen
      Molecular Pharmacology February 1985, 27 (2) 263-270;

  4. Larsson, R

    1. Characterization and mechanism of formation of reactive products formed during peroxidase-catalyzed oxidation of p-phenetidine. Trapping of reactive species by reduced glutathione and butylated hydroxyanisole.
      D Ross, R Larsson, K Norbeck, R Ryhage and P Moldéus
      Molecular Pharmacology February 1985, 27 (2) 277-286;

  5. Leff, S E

    1. Interactions of dopamine agonists with brain D1 receptors labeled by 3H-antagonists. Evidence for the presence of high and low affinity agonist-binding states.
      S E Leff, M W Hamblin and I Creese
      Molecular Pharmacology February 1985, 27 (2) 171-183;
    2. Interactions of dopaminergic agonists and antagonists with dopaminergic D3 binding sites in rat striatum. Evidence that [3H]dopamine can label a high affinity agonist-binding state of the D1 dopamine receptor.
      S E Leff and I Creese
      Molecular Pharmacology February 1985, 27 (2) 184-192;

  6. Lund, J

    1. Target cells for the polychlorinated biphenyl metabolite 4,4'-bis(methylsulfonyl)-2,2',5,5'-tetrachlorobiphenyl. Characterization of high affinity binding in rat and mouse lung cytosol.
      J Lund, I Brandt, L Poellinger, A Bergman, E Klasson-Wehler and J A Gustafsson
      Molecular Pharmacology February 1985, 27 (2) 314-323;

M

  1. Magruder, J D

    1. Ethanol-induced alterations in rat synaptosomal plasma membrane phospholipids. Relationship to changes in the phospholipid methyltransferases.
      J D Magruder, M Waid-Jones and R C Reitz
      Molecular Pharmacology February 1985, 27 (2) 256-262;

  2. McKinney, M

    1. Muscarinic responses and binding in a murine neuroblastoma clone (N1E-115). Mediation of separate responses by high affinity and low affinity agonist-receptor conformations.
      M McKinney, S Stenstrom and E Richelson
      Molecular Pharmacology February 1985, 27 (2) 223-235;

  3. Moldéus, P

    1. Characterization and mechanism of formation of reactive products formed during peroxidase-catalyzed oxidation of p-phenetidine. Trapping of reactive species by reduced glutathione and butylated hydroxyanisole.
      D Ross, R Larsson, K Norbeck, R Ryhage and P Moldéus
      Molecular Pharmacology February 1985, 27 (2) 277-286;

  4. Mong, S

    1. Characterization of guinea pig myocardial leukotriene C4 binding sites. Regulation by cations and sulfhydryl-directed reagents.
      G K Hogaboom, S Mong, J M Stadel and S T Crooke
      Molecular Pharmacology February 1985, 27 (2) 236-245;

N

  1. Neumeyer, J L

    1. A photoaffinity ligand for dopamine D2 receptors: azidoclebopride.
      H B Niznik, J H Guan, J L Neumeyer and P Seeman
      Molecular Pharmacology February 1985, 27 (2) 193-199;

  2. Niznik, H B

    1. A photoaffinity ligand for dopamine D2 receptors: azidoclebopride.
      H B Niznik, J H Guan, J L Neumeyer and P Seeman
      Molecular Pharmacology February 1985, 27 (2) 193-199;

  3. Norbeck, K

    1. Characterization and mechanism of formation of reactive products formed during peroxidase-catalyzed oxidation of p-phenetidine. Trapping of reactive species by reduced glutathione and butylated hydroxyanisole.
      D Ross, R Larsson, K Norbeck, R Ryhage and P Moldéus
      Molecular Pharmacology February 1985, 27 (2) 277-286;

P

  1. Poellinger, L

    1. Characterization of the hydrophobic properties of the receptor for 2,3,7,8-tetrachlorodibenzo-p-dioxin.
      L Poellinger and D Gullberg
      Molecular Pharmacology February 1985, 27 (2) 271-276;
    2. Target cells for the polychlorinated biphenyl metabolite 4,4'-bis(methylsulfonyl)-2,2',5,5'-tetrachlorobiphenyl. Characterization of high affinity binding in rat and mouse lung cytosol.
      J Lund, I Brandt, L Poellinger, A Bergman, E Klasson-Wehler and J A Gustafsson
      Molecular Pharmacology February 1985, 27 (2) 314-323;

R

  1. Raucy, J L

    1. Variations among untreated rabbits in benzo(a)pyrene metabolism and its modulation by 7,8-benzoflavone.
      J L Raucy and E F Johnson
      Molecular Pharmacology February 1985, 27 (2) 296-301;

  2. Reitz, R C

    1. Ethanol-induced alterations in rat synaptosomal plasma membrane phospholipids. Relationship to changes in the phospholipid methyltransferases.
      J D Magruder, M Waid-Jones and R C Reitz
      Molecular Pharmacology February 1985, 27 (2) 256-262;

  3. Richelson, E

    1. Muscarinic responses and binding in a murine neuroblastoma clone (N1E-115). Mediation of separate responses by high affinity and low affinity agonist-receptor conformations.
      M McKinney, S Stenstrom and E Richelson
      Molecular Pharmacology February 1985, 27 (2) 223-235;

  4. Ross, D

    1. Characterization and mechanism of formation of reactive products formed during peroxidase-catalyzed oxidation of p-phenetidine. Trapping of reactive species by reduced glutathione and butylated hydroxyanisole.
      D Ross, R Larsson, K Norbeck, R Ryhage and P Moldéus
      Molecular Pharmacology February 1985, 27 (2) 277-286;

  5. Ryhage, R

    1. Characterization and mechanism of formation of reactive products formed during peroxidase-catalyzed oxidation of p-phenetidine. Trapping of reactive species by reduced glutathione and butylated hydroxyanisole.
      D Ross, R Larsson, K Norbeck, R Ryhage and P Moldéus
      Molecular Pharmacology February 1985, 27 (2) 277-286;

S

  1. Schwarz, K R

    1. Rapid reciprocal changes in adrenergic receptors in intact isolated hepatocytes during primary cell culture.
      K R Schwarz, S M Lanier, E A Carter, C J Homcy and R M Graham
      Molecular Pharmacology February 1985, 27 (2) 200-209;

  2. Seeman, P

    1. A photoaffinity ligand for dopamine D2 receptors: azidoclebopride.
      H B Niznik, J H Guan, J L Neumeyer and P Seeman
      Molecular Pharmacology February 1985, 27 (2) 193-199;

  3. Seifert, W

    1. Bromobenzene metabolism in isolated rat hepatocytes. 18O2 incorporation studies.
      D Dankovic, R E Billings, W Seifert and W G Stillwell
      Molecular Pharmacology February 1985, 27 (2) 287-295;

  4. Shahinian, A H

    1. Assay and time course of 5-fluorouracil incorporation into RNA of L1210/0 ascites cells in vivo.
      C P Spears, J Shani, A H Shahinian, W Wolf, C Heidelberger and P V Danenberg
      Molecular Pharmacology February 1985, 27 (2) 302-307;

  5. Shani, J

    1. Assay and time course of 5-fluorouracil incorporation into RNA of L1210/0 ascites cells in vivo.
      C P Spears, J Shani, A H Shahinian, W Wolf, C Heidelberger and P V Danenberg
      Molecular Pharmacology February 1985, 27 (2) 302-307;

  6. Shima, S

    1. Age-related alterations in the catecholamine-sensitive adenylate cyclase system of the prostate.
      S Shima, N Akamatsu, M Hirai and H Kouyama
      Molecular Pharmacology February 1985, 27 (2) 218-222;

  7. Spears, C P

    1. Assay and time course of 5-fluorouracil incorporation into RNA of L1210/0 ascites cells in vivo.
      C P Spears, J Shani, A H Shahinian, W Wolf, C Heidelberger and P V Danenberg
      Molecular Pharmacology February 1985, 27 (2) 302-307;

  8. Spivak, C E

    1. Triphenylmethylphosphonium blocks the nicotinic acetylcholine receptor noncompetitively.
      C E Spivak and E X Albuquerque
      Molecular Pharmacology February 1985, 27 (2) 246-255;

  9. Stadel, J M

    1. Characterization of guinea pig myocardial leukotriene C4 binding sites. Regulation by cations and sulfhydryl-directed reagents.
      G K Hogaboom, S Mong, J M Stadel and S T Crooke
      Molecular Pharmacology February 1985, 27 (2) 236-245;

  10. Stenstrom, S

    1. Muscarinic responses and binding in a murine neuroblastoma clone (N1E-115). Mediation of separate responses by high affinity and low affinity agonist-receptor conformations.
      M McKinney, S Stenstrom and E Richelson
      Molecular Pharmacology February 1985, 27 (2) 223-235;

  11. Stillwell, W G

    1. Bromobenzene metabolism in isolated rat hepatocytes. 18O2 incorporation studies.
      D Dankovic, R E Billings, W Seifert and W G Stillwell
      Molecular Pharmacology February 1985, 27 (2) 287-295;

T

  1. Tsujimoto, G

    1. Desensitization of beta-adrenergic receptor-mediated vascular smooth muscle relaxation.
      G Tsujimoto and B B Hoffman
      Molecular Pharmacology February 1985, 27 (2) 210-217;

W

  1. Waid-Jones, M

    1. Ethanol-induced alterations in rat synaptosomal plasma membrane phospholipids. Relationship to changes in the phospholipid methyltransferases.
      J D Magruder, M Waid-Jones and R C Reitz
      Molecular Pharmacology February 1985, 27 (2) 256-262;

  2. Wolf, W

    1. Assay and time course of 5-fluorouracil incorporation into RNA of L1210/0 ascites cells in vivo.
      C P Spears, J Shani, A H Shahinian, W Wolf, C Heidelberger and P V Danenberg
      Molecular Pharmacology February 1985, 27 (2) 302-307;
Back to top

In this issue

Advertisement